Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on newspaper publication relating to postal ballot
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd has informed BSE that the trading window for its equity shares will remain closed from April 1, 2025 until 48 hours after the declaration of Unaudited Financial Results for the quarter ended March 31, 2025. The closure applies to Promoters, Directors, and Designated Persons, in line with the company's insider trading code and SEBI regulations. A separate intimation regarding the Board Meeting to consider and approve the Q4 FY25 results will follow. The filing is signed by the Company Secretary & Compliance Officer, Aravindkumar V.
This is a routine compliance filing ahead of quarterly results — investors should expect the Q4 FY25 earnings announcement soon, which could drive near-term stock movement.